Live feed21:00:06·4mINSIDERFilingvia QuantisnowDirector Takanashi Ken sold $23,223 worth of shares (3,864 units at $6.01) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 20,079 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.WVE· Wave Life Sciences Ltd.Health CareOriginal source